Pfizer will reportedly develop new vaccines on its own using mRNA technology

President Joe Biden listens to Pfizer CEO Albert Bourla speak at the Pfizer Kalamazoo manufacturing site on February 19, 2021, in Portage, Michigan.

Brendan Smialowski | AFP | fake images

Pfizer plans to leverage mRNA technology to make new vaccines for other viruses following the success of its Covid-19 injection, which was developed in conjunction with German partner BioNTech, The Wall Street Journal reported Tuesday.

The drug maker said it was ready to search for mRNA on its own after its experience in the past year working on the COVID-19 vaccine, the WSJ reported, citing an interview with Pfizer CEO Albert Bourla.

However, it did not reveal any details about the viruses it was targeting.

Pfizer and BioNTech did not immediately respond to Reuters requests for comment.

The Pfizer / BioNTech and Moderna Covid-19 vaccines, licensed for emergency use in the United States, use mRNA technology.

The technology’s success is prompting drug developers to consider its use in other areas of medicine beyond vaccines, attracting billions of dollars in investment.


Source link